Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks

Fiore, 2009, Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009, MMWR Recomm Rep, 58, 1 European Centre for Disease Prevention and Control (ECDC). European Influenza Surveillance Network (EISN). [2010]. 2010. Stockolm, ECDC. Available: www.ecdc.europa.eu/en/activities/surveillance/EISN Accessed 20 June 2010. Valenciano, 2008, First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States, Euro Surveill, 13., 10.2807/ese.13.43.19015-en ECDC. Protocol for case control studies to measure pandemic and seasonal vaccine effectiveness in the European Union and European Economic Area. Stockholm: European Centre for Disease Prevention and Control; 2010. Availble: http://www.ecdc.europa.eu/en/publications/Publications/0907_TED_Influenza_AH1N1_Measuring_Influenza_Vaccine_Effectiveness_Protocol_Case_Control_Studies.pdf Accessed 20 June 2010. ECDC. Protocol for cohort database studies to measure pandemic and seasonal vaccine effectiveness in the European Union and European Economic Area. Stockholm: European Centre for Disease Prevention and Control; 2010. Available: http://www.ecdc.europa.eu/en/publications/Publications/0907_TER_Influenza_AH1N1_Measuring_Influenza_Vaccine_Effectiveness_Protocol_Cohort_Database_Studies.pdf Accessed 20 June 2010. Kissling, 2009, “I-MOVE” towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9, Euro Surveill, 14, 10.2807/ese.14.44.19388-en Pitigoi, 2009, Efficiency of seasonal influenza vaccine in persons older than 65 in Romania.Pilot case-control study I-MOVE, 2008–2009, Bacteriol Virusol Parazitol Epidemiol, 54, 109 Savulescu, 2010, Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network-Pilot case-control studies using different control groups 2008–2009 season, Spain, Vaccine, 10.1016/j.vaccine.2010.01.054 Carrat, 2007, Influenza vaccine: the challenge of antigenic drift, Vaccine, 25, 6852, 10.1016/j.vaccine.2007.07.027 Nichol, 2009, Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy, Vaccine, 27, 6305, 10.1016/j.vaccine.2009.07.006 Nichol, 2006, Heterogeneity of influenza case definitions and implications for interpreting and comparing study results, Vaccine, 24, 6726, 10.1016/j.vaccine.2006.05.064 Orenstein, 1985, Field evaluation of vaccine efficacy, Bull World Health Organ, 63, 1055 Govaert, 1994, The efficacy of influenza vaccination in elderly individuals.A randomized double-blind placebo-controlled trial, JAMA, 272, 1661, 10.1001/jama.272.21.1661 Nichol, 2004, Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses, Virus Res, 103, 3, 10.1016/j.virusres.2004.02.005 Foster, 1992, Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly, Am J Epidemiol, 136, 296, 10.1093/oxfordjournals.aje.a116495 Puig-Barbera, 2007, Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly, Vaccine, 25, 7313, 10.1016/j.vaccine.2007.08.039 Orenstein, 2007, Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness, Int J Epidemiol, 36, 623, 10.1093/ije/dym021 Klimov, 1995, Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis 1, J Infect Dis, 172, 1352, 10.1093/infdis/172.5.1352 Leekha, 2007, Duration of influenza A virus shedding in hospitalized patients and implications for infection control 5, Infect Control Hosp Epidemiol, 28, 1071, 10.1086/520101 Sato, 2005, Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors, Pediatr Infect Dis J, 24, 931, 10.1097/01.inf.0000180976.81055.ce Weinstock, 2003, Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient, N Engl J Med, 348, 867, 10.1056/NEJM200302273480923 Lee, 2009, Viral loads and duration of viral shedding in adult patients hospitalized with influenza 8, J Infect Dis, 200, 492, 10.1086/600383 De, 2010, Contagious period for pandemic (H1N1) 2009 1, Emerg Infect Dis, 16, 783, 10.3201/eid1605.091894 Mangtani, 2004, A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database, J Infect Dis, 190, 1, 10.1086/421274 Nichol, 2007, Effectiveness of influenza vaccine in the community-dwelling elderly, N Engl J Med, 357, 1373, 10.1056/NEJMoa070844 Hak, 2002, Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications, J Epidemiol Community Health, 56, 951, 10.1136/jech.56.12.951 Jackson, 2006, Evidence of bias in estimates of influenza vaccine effectiveness in seniors, Int J Epidemiol, 35, 337, 10.1093/ije/dyi274 Simonsen, 2009, Influenza vaccination and mortality benefits: new insights, new opportunities, Vaccine, 27, 6300, 10.1016/j.vaccine.2009.07.008 Jackson, 2006, Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors, Int J Epidemiol, 35, 345, 10.1093/ije/dyi275 Belongia, 2009, Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004–2005 season to the 2006–2007 season, J Infect Dis, 199, 159, 10.1086/595861 Skowronski, 2007, Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005–2006 season of dual A and B vaccine mismatch in Canada, Vaccine, 25, 2842, 10.1016/j.vaccine.2006.10.002 Gruber, 1993, Comparison of monovalent and trivalent live attenuated influenza vaccines in young children, J Infect Dis, 168, 53, 10.1093/infdis/168.1.53 Ortqvist, 2007, Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area, Eur Respir J, 30, 414, 10.1183/09031936.00135306 Ozasa, 2006, Retrospective assessment of influenza vaccine effectiveness among the non-institutionalized elderly population in Japan, Vaccine, 24, 2537, 10.1016/j.vaccine.2005.12.022 Tacken, 2004, Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data, Vaccine, 22, 2985, 10.1016/j.vaccine.2004.02.017 Vila-Corcoles, 2007, Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002–2005 influenza periods, Vaccine, 25, 6699, 10.1016/j.vaccine.2007.07.015 Jackson, 2008, Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study, Lancet, 372, 398, 10.1016/S0140-6736(08)61160-5 Castilla, 2006, Incidence of influenza and influenza vaccine effectiveness in the 2004–2005 season, An Sist Sanit Navar, 29, 97 Fleming, 1995, Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989–90 using a general practice database, Epidemiol Infect, 115, 581, 10.1017/S095026880005874X Voordouw, 2006, Annual influenza vaccination in community-dwelling elderly individuals and the risk of lower respiratory tract infections or pneumonia, Arch Intern Med, 166, 1980, 10.1001/archinte.166.18.1980 Hviid, 2009, Effectiveness of two pertussis vaccines in preterm Danish children, Vaccine, 27, 3035, 10.1016/j.vaccine.2009.03.041 Simonsen, 2007, Mortality benefits of influenza vaccination in elderly people: an ongoing controversy, Lancet Infect Dis, 7, 658, 10.1016/S1473-3099(07)70236-0 Halloran, 2001, Using validation sets for outcomes and exposure to infection in vaccine field studies, Am J Epidemiol, 154, 391, 10.1093/aje/154.5.391 Scharfstein, 2006, On estimation of vaccine efficacy using validation samples with selection bias, Biostatistics, 7, 615, 10.1093/biostatistics/kxj031 Skowronski, 2009, Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006–2007, J Infect Dis, 199, 168, 10.1086/595862 Kelly, 2009, Estimation of influenza vaccine effectiveness from routine surveillance data, PLoS One, 4, e5079, 10.1371/journal.pone.0005079 Fleming, 2009, Estimating Influenza vaccine effectiveness using routinely collected laboratory data 2, J Epidemiol Community Health Uphoff, 2006, Estimation of influenza vaccine effectiveness using routine surveillance data 5, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 49, 287, 10.1007/s00103-006-1233-8 Rodrigues, 2010, Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls, Int J Epidemiol, 19, 205, 10.1093/ije/19.1.205 Mazick, 2006, Using sentinel surveillance to monitor effectiveness of influenza vaccine is feasible: a pilot study in Denmark, Euro Surveill, 11, 254, 10.2807/esm.11.10.00654-en Mereckiene, 2008, Low coverage of seasonal influenza vaccination in the elderly in many European countries, Euro Surveill, 13, 10.2807/ese.13.41.19001-en Carrat, 1998, Field investigation of influenza vaccine effectiveness on morbidity, Vaccine, 16, 893, 10.1016/S0264-410X(97)00307-1 Farrington, 1993, Estimation of vaccine effectiveness using the screening method, Int J Epidemiol, 22, 742, 10.1093/ije/22.4.742 Legrand, 2006, Real-time monitoring of the influenza vaccine field effectiveness, Vaccine, 24, 6605, 10.1016/j.vaccine.2006.05.063 2009, Effectiveness of 2008–09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States May-June 2009, MMWR Morb Mortal Wkly Rep, 58, 1241 Wichmann, 2010, Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009–2010, Euro Surveill, 15, 10.2807/ese.15.18.19561-en ECDC. Protocol for cluster investigations to measure pandemic and seasonal vaccine effectiveness in the EU and EEA. European Centre for Disease Prevention and Control; 2010. Available: http://www.ecdc.europa.eu/en/publications/Publications/0912_TED_Protocol_for_Cluster_Investigations_to_Measure_Influenza_Vaccine_Effectiveness.pdf Accessed 20 June 2010.